Long COVID inflammation stems not from a single runaway process but from several overlapping mechanisms that feed each other: lingering viral material that keeps the immune system on alert, a flood of signaling molecules that never fully subsides, autoantibodies that attack the body’s own receptors, microscopic blood clots that starve tissues of oxygen, and damage to the lining of blood vessels that compounds all of the above. A meta-analysis pooling data from studies at various time points found that key inflammatory markers, including IL-6, TNF-α, and IFN-γ, remain elevated in people with persistent symptoms compared with those who recovered fully, and that some of these markers stay high beyond six months after the initial infection.1PubMed. Persistent inflammatory cytokine signature in long Covid-19 patients: a meta-analysis Understanding how each of these threads connects to the fatigue, brain fog, chest pain, and other symptoms people actually experience is where the science has made real progress in recent years.
Viral Persistence as the Spark That Won’t Go Out
One of the most compelling explanations for why inflammation persists is that the virus itself, or fragments of its genetic material, never fully clears. Researchers have found reservoirs of SARS-CoV-2 RNA lingering for months to years in multiple organs, including the gut, lungs, and brain tissue. These viral remnants act as a continuous source of stimulation for the immune system, driving chronic inflammation and exhausting the very T cells responsible for clearing infections.2PubMed Central. Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID Think of it as an alarm that keeps ringing because the sensor still detects something, even if the fire is mostly out.
This viral persistence does more than just irritate immune cells. SARS-CoV-2 infection can also reawaken dormant viruses already living in the body, particularly Epstein-Barr virus (EBV), which most adults carry. Multiple studies have linked EBV reactivation to Long COVID symptoms such as fatigue, cognitive impairment, and muscle pain. One longitudinal study of over 300 COVID-19 patients found that EBV viremia was associated with ongoing fatigue. Separate research confirmed that symptoms like brain fog at four months post-infection were independently tied to recent EBV reactivation, and that varicella-zoster virus (the cause of chickenpox and shingles) could also be stirred back to life by the inflammatory environment SARS-CoV-2 creates.3Molecular Psychiatry. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID – Section: Reactivation of Epstein–Barr virus (EBV) So in some patients, what looks like one infection causing long-term problems may actually be two or three infections conspiring together.
The Cytokine Storm That Never Fully Passes
During acute COVID-19, the body unleashes a barrage of inflammatory signaling molecules called cytokines. In most people, this calms down as the infection resolves. In Long COVID, it doesn’t. The immune system settles into a state of chronic, low-grade inflammation where cytokines remain elevated well past the point when they should have returned to normal. This ongoing chemical signaling has been proposed as the link between the initial lung infection and the bewildering range of symptoms that follow: fatigue, joint pain, brain fog, gut problems, nerve tingling, and even vision changes.4PubMed Central. A review of cytokine-based pathophysiology of Long COVID symptoms
Not all cytokines behave the same way across patients, and the variant that caused the original infection seems to matter. When researchers compared cytokine profiles by SARS-CoV-2 variant, they found that IL-1β was significantly and persistently elevated in people infected during the wild-type/alpha, beta, and gamma waves but not in those infected during the delta and omicron waves. TNF-α stayed high across most variant eras but dropped in the omicron group.5PubMed Central. Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs This finding helps explain why some people infected early in the pandemic seem to have more entrenched inflammatory patterns than those infected later, though individual variation still plays a large role.
Some researchers suspect that this chronic cytokine activity, combined with genetic differences in how people regulate inflammation, can tip certain patients toward autoimmunity. Changes to how cytokine genes are expressed, possibly induced by the virus itself, may predispose some individuals to conditions resembling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).4PubMed Central. A review of cytokine-based pathophysiology of Long COVID symptoms
Autoantibodies Turning the Body Against Itself
In a striking twist, the immune disruption of COVID-19 can cause the body to manufacture antibodies that attack its own tissues. Researchers studying recovered patients found that all 31 people examined had between two and seven different functional autoantibodies targeting a class of cell-surface receptors involved in heart rate, blood pressure, and vascular tone. Nearly every patient had autoantibodies against the β2-adrenoceptor and the muscarinic M2 receptor, while about 90% also had autoantibodies targeting the angiotensin II AT1 receptor and the angiotensin 1-7 MAS receptor. In patients who experienced post-infection hair loss, additional autoantibodies were detected.6Journal of Translational Autoimmunity. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms – Section: Results These autoantibodies don’t just float around harmlessly; they functionally activate or inhibit the receptors they bind, which could explain why Long COVID patients experience such volatile shifts in heart rate, blood pressure, and overall autonomic regulation.
The Complement System and Thromboinflammation
Beyond cytokines and autoantibodies, another branch of the innate immune system appears to stay stuck in overdrive: the complement system. This network of proteins normally helps clear pathogens and damaged cells, but when it stays activated chronically, it causes tissue damage. A large proteomic study analyzing over 6,500 proteins in 268 longitudinal samples found that people with active Long COVID had persistent dysregulation of both the classical and alternative complement pathways, alongside increased markers of hemolysis, tissue injury, and platelet activation.7PubMed. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid Separately, researchers confirmed that markers spanning all three complement pathways, including the terminal attack complex, were significantly elevated in Long COVID patients.8PubMed. Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
The complement findings are particularly interesting because they connect inflammation directly to clotting. When complement proteins activate platelets and damage vessel walls, the result is what researchers call thromboinflammation, a self-reinforcing loop where inflammation triggers clotting and clotting triggers more inflammation. This loop shows up vividly in the form of fibrin amyloid microclots, abnormal clot structures found in the blood plasma of Long COVID patients. These microclots are resistant to the body’s normal clot-dissolving mechanisms, can trap other proteins (including inflammatory ones), and are small enough to physically block capillaries, starving tissues of oxygen.9PubMed Central. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications Researchers have argued that this capillary blockage alone could account for the majority of Long COVID symptoms, from exercise intolerance to cognitive problems.10PubMed Central. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
Blood Vessel Damage That Lingers
Underneath the clotting problem lies a more fundamental issue: the endothelium, the single-cell-thick lining of every blood vessel, sustains lasting injury. A systematic review found that Long COVID is clearly associated with endothelial dysfunction, characterized by increased vascular tone and impaired ability of blood vessels to relax in response to blood flow. Inflammation driven by IL-6 reduces the availability of nitric oxide, the molecule that normally keeps vessels relaxed and blood flowing smoothly. Oxidative stress compounds the damage, as highly reactive molecules generated during inflammation attack the very proteins and fats that make up the vessel lining.11PubMed Central. Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review – Section: 3.1.2. Endothelial Dysfunction in Long COVID
This isn’t just theoretical. Researchers using retinal imaging, which allows noninvasive measurement of tiny blood vessels, demonstrated that Long COVID patients had measurably narrower arteries and reduced vessel responsiveness compared with healthy controls. More severe symptom scores correlated with worse microvascular measurements, and those associations were amplified in patients who also had elevated inflammatory markers.12PubMed Central. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation The endothelium isn’t just a passive tube; it actively regulates clotting, immune-cell recruitment, and fluid balance. When it malfunctions throughout the body, the downstream effects touch virtually every organ.
There’s also evidence that endothelial cells themselves can enter a state of senescence, essentially aging prematurely and pumping out inflammatory signals of their own. This senescent endothelium may promote immune exhaustion, creating yet another feedback loop where the damaged vessels make the immune dysfunction worse and vice versa.13Cell Death & Disease. Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID
How the Inflammation Spreads Across Organ Systems
Because the mechanisms above, persistent cytokines, complement activation, microclots, and endothelial damage, affect blood vessels everywhere, Long COVID inflammation isn’t confined to one body part. Its systemic nature is what makes the condition so bewildering for patients and clinicians alike.
Heart and Lungs
Cardiac involvement is among the most concerning downstream effects. A case-control study using advanced cardiac imaging found that patients who had been critically ill with COVID-19 showed reduced blood flow to the heart muscle under stress about ten months later, indicating coronary microvascular dysfunction, along with declining measures of heart squeezing function.14JAMA Network Open. Long-Term Coronary Microvascular and Cardiac Dysfunction After Severe COVID-19 Hospitalization Meanwhile, a systematic review found that lung damage, including fibrotic remodeling and persistent microthrombosis, places ongoing strain on the heart by worsening arrhythmias and myocardial inflammation.15PubMed Central. Cardiopulmonary crosstalk in Long COVID: a systematic review of emerging evidence The lungs and heart form a tight loop: when one suffers, the other is pulled down with it.
On the pulmonary side, many persistent symptoms have been linked to fibrotic lung lesions and diminished respiratory function. Whether this scarring stabilizes, reverses, or progresses over time remains an open question. Studies have documented ongoing lung impairment up to three years after COVID-19, and data from the original SARS outbreak in 2003 suggest pulmonary damage can persist for fifteen years or more after a similar coronavirus infection.16PubMed. Post-COVID pulmonary sequelae: Mechanisms and potential targets to reduce persistent fibrosis
Brain and Nervous System
Neuroinflammation has emerged as a key driver of the cognitive and psychiatric symptoms grouped under the term “brain fog.” Sustained activation of microglia (the brain’s resident immune cells) and astrocytes, combined with disruption of the blood-brain barrier, allows inflammatory signaling to spill into the central nervous system. This creates a self-reinforcing cycle where peripheral cytokines entering the brain trigger even more central cytokine release.17Translational Psychiatry. Understanding neuroinflammation in post-COVID-19 syndrome: biological mechanisms, diagnostic biomarkers, and therapeutic prospects
The autonomic nervous system, which controls heart rate, blood pressure, digestion, and other involuntary functions, also takes a direct hit. Postmortem analysis of vagus nerves from COVID-19 patients found SARS-CoV-2 RNA alongside inflammatory cell infiltration, and gene sequencing revealed a strong inflammatory response in the nerve’s neurons and surrounding cells that correlated with viral load.18PubMed Central. Vagus nerve inflammation contributes to dysautonomia in COVID-19 Vagus nerve inflammation provides a plausible explanation for the dysautonomia, including rapid heart rate on standing, blood pressure swings, and disordered digestion, that many Long COVID patients report.
Gut Microbiome
SARS-CoV-2 uses the ACE2 receptor to enter cells, and ACE2 is abundantly expressed in the gut lining. When viral infection downregulates ACE2, it disrupts both the gut microbiome and the broader regulatory system that ACE2 participates in. The resulting imbalance in gut bacteria has been linked to a range of Long COVID symptoms, from joint pain and fatigue to anxiety and impaired concentration.19PubMed Central. Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health The gut houses roughly 70% of the body’s immune tissue, so a destabilized microbiome can amplify systemic inflammation far beyond the digestive tract.
Why Exercise Makes It Worse
One of the most debilitating features of Long COVID is post-exertional malaise: a worsening of symptoms after physical or mental effort that would have been routine before illness. Mitochondria, the structures inside cells that generate energy, appear to be centrally involved. Researchers have pointed to mitochondrial dysfunction as a potential underpinning mechanism for chronic fatigue, cognitive disturbances, and exercise intolerance in Long COVID.20PubMed Central. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
A study that performed muscle biopsies on Long COVID patients found something striking: after maximal exercise, both healthy controls and patients showed a drop in mitochondrial energy-production capacity, which is expected. But only the Long COVID group also showed a decrease in the activity of a key mitochondrial enzyme, indicating that their mitochondrial content itself was reduced. The combination of lower peak capacity and fewer functioning mitochondria helps explain why even moderate exertion can trigger a crash.21Nature Communications. Muscle abnormalities worsen after post-exertional malaise in long COVID
Who Gets Hit Hardest and Why
Long COVID affects women more often than men, and the immune mechanisms behind this disparity are becoming clearer. Research into sex-specific immune pathways found that men who went on to develop Long COVID showed increased TGF-β signaling during acute infection, while women who developed it actually had reduced expression of the same pathway. Women who later developed Long COVID also showed increased expression of XIST, a gene implicated in autoimmunity, during their acute illness.22PubMed Central. Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution Beyond immune differences, Long COVID has been linked to hormonal disruption and menstrual irregularities in women, with potential effects on ovarian function.23PubMed Central. Clinical Spectrum of Long COVID: Effects on Female Reproductive Health
Genetics play a role too. Combinatorial analysis has identified dozens of genes highly associated with Long COVID risk, with genes unique to severe Long COVID clustering in immune pathways related to myeloid cell function, while genes linked to the fatigue-dominant subtype clustered in metabolic signaling pathways.24PubMed Central. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis A separate study in a Colombian population found that a specific variant in the IL10RB gene, which encodes part of the receptor for the anti-inflammatory cytokine IL-10, was significantly associated with developing Long COVID, with carriers having roughly 2.5 times the odds.25PubMed Central. Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population
Children are not immune to Long COVID, but their inflammatory profile looks different from adults’. Compared with pediatric patients, adult COVID-19 patients had significantly higher levels of several matrix metalloproteinases (enzymes that remodel tissue and can drive inflammation) as well as TNF-α, suggesting a more intense tissue-remodeling response in adults that may predispose them to more lasting damage.26Medical Science Monitor. Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment
Overlaps With ME/CFS and What Biomarkers Reveal
The resemblance between Long COVID and ME/CFS has drawn attention since the pandemic’s first year, and the biomarker overlaps are real. A prospective cohort study comparing both conditions against healthy controls found that Long COVID and ME/CFS patients shared elevated levels of endothelin-1 (a powerful blood-vessel constrictor), VCAM-1 (a marker of endothelial activation), and TNF-α, alongside reduced nitric oxide availability.27Journal of Translational Medicine. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study The conditions are not identical, however: Long COVID patients had lower levels of thrombospondin-1 (an anti-angiogenic protein), suggesting that the vascular dysfunction may differ in its fine details even if the broad strokes overlap.
Clinicians looking for objective markers of Long COVID have converged on a core set of blood tests: IL-6, C-reactive protein, and TNF-α form the baseline. For patients with neurological symptoms, markers like neurofilament light chain and glial fibrillary acidic protein may add diagnostic value. For those with primarily pulmonary symptoms, CXCL10 and TGF-β have been proposed as useful additions.28PubMed Central. Biomarkers in long COVID-19: A systematic review – Section: Future directions toward the use of biomarkers No single blood test yet confirms or rules out Long COVID, but the direction of research suggests that a panel approach, tailored to the patient’s dominant symptoms, could make diagnosis more objective in the near future.
Where Anti-Inflammatory Treatment Stands
If inflammation is the engine of Long COVID, then anti-inflammatory drugs should help, at least in theory. Researchers have begun testing this idea directly. A randomized trial enrolled roughly 350 participants in India with confirmed SARS-CoV-2 infection and persistent symptoms, assigning them to receive colchicine (a well-established anti-inflammatory drug) or placebo for 26 weeks.29JAMA. Long COVID Trial Explores Anti-Inflammatory Treatment Results from that trial and others exploring complement-targeted therapies will help clarify which inflammatory pathways are most important to interrupt. The complement findings in particular are considered therapeutically promising, because drugs that target complement activation already exist for other conditions.8PubMed. Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
For now, no approved drug specifically targets Long COVID inflammation. Treatment remains symptom-based, and the honest takeaway from the research is that the condition involves so many inflammatory pathways simultaneously that a single drug is unlikely to work for everyone. A therapy that calms complement activation might help a patient whose disease is driven by thromboinflammation but do little for someone whose primary issue is viral persistence reactivating EBV. Getting the right treatment to the right patient will eventually require the kind of biomarker-guided approach researchers are building now, but that’s still a few steps away from the clinic.